Eli Lilly Reduces Insulin Prices To $35 Per Month
Drugmaker Eli Lilly is cutting prices for its insulin and capping costs at $35 per month
Eli Lilly is reducing prices for insulin and capping the costs at $35 per month. Out-of-pocket expenses will not exceed this amount for those with commercial insurance using Lilly insulin. People without insurance may still be able to get help through a savings card program.
The company is also cutting the price of two common insulins, Humalog and Humulin, by 70 percent but it might take some time to implement these changes in the healthcare system. David Ricks, CEO of Eli Lilly, wants others such as policymakers and employers to join him in making insulin more affordable. This cap matches up with one already set up for Medicare beneficiaries under an act concerning inflation reduction.
There has been a lot of pressure from lawmakers and advocates to make this life-sustaining drug more affordable.
Read more here:
What else matters right now?
1. Former CIA Director John Brennan said he sees a “hung jury” among U.S. intelligence agencies about the origins of the COVID-19 pandemic in the aftermath of FBI Director Christopher Wray saying his agency believes the virus escaped from a lab.
2. Move comes amid criticism of healthcare companies over rising costs of insulin, as CEO says cuts ‘should be the new standard’
3. Ex-minister’s judgment questioned for trusting journalist who has long made clear her disdain for his lockdown policies
This post is part of The Top News Review’s hourly update service, which delivers the stories going viral right now (according to actual data). The four links above currently have the highest trending score (respectively) on BuzzSumo over the past hour, filtered for reliable sources.
Check back regularly and always know what matters.
AI Disclaimer
Medium welcomes the responsible use of AI-assistive technology. This article used editorial assistance from GPT-3.
